| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $8,556,833 ) |
| | 2024 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01HL154757 | DOT1L, reconstitution of plasmacytoid dendritic cells and alloimmunity | 000 | 4 | NIH | 4/18/2024 | $570,153 |
| | 2024 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R37CA250661 | Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells | 001 | 3 | NIH | 4/17/2024 | $27,724 |
| | 2024 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R00CA245488 | Leveraging behavioral science to improve patient understanding of advanced cancer | 000 | 5 | NIH | 3/21/2024 | $224,101 |
| | 2024 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R00CA245488 | Leveraging behavioral science to improve patient understanding of advanced cancer | 001 | 5 | NIH | 4/18/2024 | $24,899 |
| | 2024 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R21AI174118 | Identifying drug-resistant Candida species using SuperSelective primer PCR | 000 | 2 | NIH | 10/30/2023 | $183,368 |
| | 2024 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R21AI168729 | Elucidating mediators of genetic instability in Candida glabrata | 000 | 2 | NIH | 10/25/2023 | $209,973 |
| | 2024 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA270252 | Identifying and characterizing functional noncoding mutations in multiple myeloma | 000 | 2 | NIH | 3/13/2024 | $665,916 |
| | 2024 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA270252 | Identifying and characterizing functional noncoding mutations in multiple myeloma | 001 | 2 | NIH | 4/22/2024 | $36,996 |
| | 2024 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI145436 | Translational approaches to improve understanding and outcome in Tuberculous meningitis | 000 | 5 | NIH | 3/20/2024 | $747,157 |
| | 2024 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 2B2CMS331786 | Integrated Care for Kids (InCK) | 00 | 5 | CMS | 12/15/2023 | $2,000,000 |
| | 2024 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI112579 | Tcf1 programs CD8 T cell responses to enhance viral and cancer immunity | 000 | 9 | NIH | 4/30/2024 | $516,631 |
| | 2024 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 2B2CMS331786 | Integrated Care for Kids (InCK) | 01 | 5 | CMS | 2/15/2024 | $0 |
| | 2024 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA290808 | ID3 regulation of tissue-infiltrating T cells mediating graft-versus-host disease and leukemia rejection | 000 | 1 | NIH | 4/30/2024 | $752,830 |
| | 2024 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01NS133233 | Neutrophil extracellular traps and associated pathogenesis in TBI: a novel peptide therapeutic strategy. | 000 | 1 | NIH | 3/5/2024 | $442,750 |
| | 2024 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R37CA250661 | Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells | 000 | 3 | NIH | 1/29/2024 | $498,997 |
| | 2024 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI150765 | Immunometabolic regulations of pulmonary TB pathogenesis by adiposetissue | 000 | 6 | NIH | 12/22/2023 | $687,767 |
| | 2024 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | U19AI142731 | Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents | 000 | 5 | NIH | 3/1/2024 | $0 |
| | 2024 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA239716 | Study of Interleukin 33 as a new immunotherapy of lung cancer | 000 | 6 | NIH | 11/1/2023 | $0 |
| | 2024 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01DE028961 | Dissecting cell composition and drug sensitivity in human adenoid cystic carcinomas (ACCs) | 001 | 6 | NIH | 4/30/2024 | $178,670 |
| | 2024 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 2B2CMS331786 | Integrated Care for Kids (InCK) | 04 | 4 | CMS | 12/20/2023 | $0 |
| | 2024 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI084385 | I.C.A.R.E. - Integrated Care for Addiction Recovery Expansion | 000 | 3 | SAMHSA | 2/9/2024 | $0 |
| | 2024 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI083671 | HMH Youth and Family TREE Program | 000 | 1 | SAMHSA | 11/30/2023 | $0 |
| | 2024 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI083671 | HMH Youth and Family TREE Program | 001 | 1 | SAMHSA | 3/12/2024 | $0 |
| | 2024 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | CE152512 | Community Project Funding/Congressionally Directed Spending - Construction | 02 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | CE152512 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/8/2023 | $0 |
| | 2024 | 2022 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI106398 | Target based discovery of next generation pyrazinamide | 000 | 9 | NIH | 2/27/2024 | $0 |
| | 2024 | 2022 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | CE147180 | Community Project Funding/Congressionally Directed Spending - Construction | 03 | 1 | HRSA | 10/11/2023 | $0 |
| | 2024 | 2022 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | CE147180 | Community Project Funding/Congressionally Directed Spending - Construction | 04 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2022 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | CE146126 | Community Project Funding/Congressionally Directed Spending - Construction | 04 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2022 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | T2246942 | Dental Reimbursement Program | 01 | 1 | HRSA | 10/17/2023 | $0 |
| | 2024 | 2022 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA254274 | Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy | 001 | 3 | NIH | 4/16/2024 | $6,798 |
| | 2024 | 2022 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA239716 | Study of Interleukin 33 as a new immunotherapy of lung cancer | 002 | 5 | NIH | 4/16/2024 | $14,497 |
| | 2024 | 2022 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA222090 | Using a Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening | 002 | 6 | NIH | 4/12/2024 | $265,527 |
| | 2024 | 2021 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI090155 | The molecular basis of the carbapenem resistance epidemic | 000 | 11 | NIH | 10/18/2023 | $0 |
| | 2024 | 2021 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 90DPTB0036 | Disability and Rehabilitation Research Projects (DRRP) Program: Traumatic Brain Injury (TBI) Model System Centers Program - 2017 | 00 | 1 | ACL | 2/23/2024 | $437,854 |
| | 2024 | 2020 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 90DPTB0036 | Disability and Rehabilitation Research Projects (DRRP) Program: Traumatic Brain Injury (TBI) Model System Centers Program - 2017 | 00 | 1 | ACL | 2/23/2024 | $25,977 |
| | 2024 | 2020 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI121080 | Tcf/Lef and B-catenin pathway in follicular helper T cells | 000 | 5 | NIH | 2/1/2024 | $0 |
| | 2024 | 2019 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 90DPTB0036 | Disability and Rehabilitation Research Projects (DRRP) Program: Traumatic Brain Injury (TBI) Model System Centers Program - 2017 | 00 | 1 | ACL | 2/23/2024 | $38,249 |
|
| Issue Date FY: 2023 ( Subtotal = $26,190,711 ) (Continued on the next page) |
| | 2023 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | U19AI142731 | Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents | 001 | 5 | NIH | 5/30/2023 | $0 |
| | 2023 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI141183 | Novel bi-specific immunotherapeutic against high-threat Gram-negative pathogens | 000 | 5 | NIH | 2/6/2023 | $1,142,038 |
| | 2023 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA239716 | Study of Interleukin 33 as a new immunotherapy of lung cancer | 002 | 6 | NIH | 9/1/2023 | $433,485 |
| | 2023 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA254274 | Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy | 002 | 4 | NIH | 5/12/2023 | $393,090 |
| | 2023 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79SM084539 | Hackensack Meridian Carrier Clinic Mental Health Awareness in Identifying Disturbances in Emotions Program (AIDE) | 000 | 3 | SAMHSA | 6/8/2023 | $124,655 |
| | 2023 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R00CA245123 | Elucidating the Role of SMAD4 in Colorectal Cancer | 000 | 4 | NIH | 7/7/2023 | $249,000 |
| | 2023 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R00CA229979 | Experimental evolution of pancreatic cancer | 000 | 4 | NIH | 8/10/2023 | $249,000 |
| | 2023 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI150765 | Immunometabolic regulations of pulmonary TB pathogenesis by adiposetissue | 000 | 5 | NIH | 12/15/2022 | $764,187 |
| | 2023 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R21AI168729 | Elucidating mediators of genetic instability in Candida glabrata | 000 | 1 | NIH | 11/9/2022 | $277,372 |
| | 2023 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | U19AI142731 | Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents | 000 | 5 | NIH | 4/21/2023 | $6,521,325 |
|
